Antiarrhythmic Drug Use in Patients <65 Years of Age With Atrial Fibrillation and Without Structural Heart Disease

Little is known in clinical practice about antiarrhythmic drug (AAD) use in atrial fibrillation (AF) patients (particularly younger ones) that do not have structural heart disease. Using the MarketScan(®) database, we identified patients <65 years of age without known coronary artery disease or h...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Cardiol
Prif Awduron: Allen LaPointe, Nancy M., Dai, Dadi, Thomas, Laine, Piccini, Jonathan P., Peterson, Eric D., Al-Khatib, Sana M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293335/
https://ncbi.nlm.nih.gov/pubmed/25491240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2014.11.005
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg